These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26816)

  • 21. Desensitization of patients with inflammatory bowel disease to sulfasalazine.
    Taffet SL; Das KM
    Am J Med; 1982 Oct; 73(4):520-4. PubMed ID: 6127032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [40 years of salazosulfapyridine. Is end in sight?].
    van Hees PA; van Tongeren JH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2014-8. PubMed ID: 6129576
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfasalazine hepatotoxicity.
    Fich A; Schwartz J; Braverman D; Zifroni A; Rachmilewitz D
    Am J Gastroenterol; 1984 May; 79(5):401-2. PubMed ID: 6144268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulfasalazine pneumonitis.
    Yaffe BH; Korelitz BI
    Am J Gastroenterol; 1983 Aug; 78(8):493-4. PubMed ID: 6136183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfasalazine-induced fulminant hepatic failure.
    Marinos G; Riley J; Painter DM; McCaughan GW
    J Clin Gastroenterol; 1992 Mar; 14(2):132-5. PubMed ID: 1348259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypersensitivity reaction to sulfasalazine--two reports of the same patient.
    Blackstone MO
    Gastroenterology; 1978 Dec; 75(6):1192-3. PubMed ID: 30677
    [No Abstract]   [Full Text] [Related]  

  • 27. Sargramostim for sulfasalazine-induced agranulocytosis.
    Rospond RM; Glowacki RC; Mailliard JA
    Clin Pharm; 1993 Mar; 12(3):179. PubMed ID: 8098278
    [No Abstract]   [Full Text] [Related]  

  • 28. Granulomatous hepatitis associated with salicylazosulfapyridine therapy.
    Callen JP; Soderstrom RM
    South Med J; 1978 Sep; 71(9):1159-60. PubMed ID: 28568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety of sulfasalazine: the gastroenterologists' experience.
    Sachar DB
    J Rheumatol Suppl; 1988 Sep; 16():14-6. PubMed ID: 2903923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A severe case of infectious mononucleosis associated with ciprofloxacin and salazopyrin administration].
    Miftode E; Leca D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(3):652-5. PubMed ID: 20201247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse reactions to sulphasalazine and 5-amino salicylic acid in the same patient.
    Burke DA; Manning AP; Williamson JM; Axon AT
    Aliment Pharmacol Ther; 1987 Jun; 1(3):201-8. PubMed ID: 2908750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease].
    Besnard M; Debray D; Durand P; Fabre M; Chardot C; Cézard JP
    Arch Pediatr; 1999 Jun; 6(6):643-6. PubMed ID: 10394456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical effect of salazosulphapyridine (Salazopyrin r) in Crohn's disease. A controlled double-blind study.
    Anthonisen P; Barany F; Folkenborg O; Holtz A; Jarnum S; Kristensen M; Riis P; Walan A; Worning H
    Scand J Gastroenterol; 1974; 9(6):549-54. PubMed ID: 4153646
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.
    Petkov T; Pehlivanov G; Grozdev I; Kavaklieva S; Tsankov N
    Eur J Dermatol; 2007; 17(5):422-7. PubMed ID: 17673387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticonvulsant hypersensitivity syndrome (AHS): a case report.
    Keel BR; Payne CL
    Tenn Med; 2013 Apr; 106(4):35-6, 38. PubMed ID: 23617037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pruritus, exanthema, icterus and fever].
    Groth H; Rhyner K; Vetter W
    Schweiz Rundsch Med Prax; 1987 May; 76(20):570-4. PubMed ID: 3629058
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatitis caused by salicylazosulfapyridine].
    Falguera Sacrest M; de Celis Bernat G; Pintó Sala J; Baliellas Comellas C
    Med Clin (Barc); 1986 Apr; 86(16):696-7. PubMed ID: 2874272
    [No Abstract]   [Full Text] [Related]  

  • 38. [Life-threatening liver failure and severe dyscrasias in blood and lymph nodes caused by sulphasalazine].
    Kampmann P; Højlyng N; Pedersen M
    Ugeskr Laeger; 2006 Sep; 168(39):3331-3. PubMed ID: 17032600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abrupt occurrence of high fever and rash in a patient treated with sulphasalazine for psoriatic arthritis.
    Fischetti F; Gerloni R; Bardelli M; Carretta R
    Minerva Med; 2003 Dec; 94(6):437-44. PubMed ID: 14976471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.